Target intelligence / Profile preview

Resistance to inhibitors of cholinesterase-8A (RIC8A)

Target
RIC8A
Molecular classification
Guanine nucleotide exchange factor (GEF), Molecular chaperone, ARM/HEAT repeat-containing protein, Cytosolic signaling protein
01

Overview

Resistance to inhibitors of cholinesterase-8A (RIC8A) is a cytosolic protein acting as both a **guanine nucleotide exchange factor** and a **molecular chaperone** for specific classes of heterotrimeric G protein α-subunits (Gαi, Gαq, and Gα12/13)[1][3][4]. Unlike GPCRs, RIC8A’s guanine nucleotide exchange function occurs in the cytosol and is vital for the correct folding, biogenesis, and localization of Gα proteins to the membrane, thus ensuring their capability for signaling. RIC8A is essential for processes like asymmetric cell division, embryogenesis, and neural development due to its role in G protein signaling outside of canonical receptor mechanisms[3][2][7]. The protein has a core armadillo (ARM)/HEAT repeat structure and a flexible C-terminal region critical for both chaperone and GEF activities[1][2][4]. Disruption of RIC8A leads to profound developmental defects and affects cell polarity, cell cycle, and signal transduction. It is not a receptor or enzyme in the classical drug development sense but is conceptually a signaling cofactor and chaperone. There are currently no drugs directly targeting RIC8A, and its critical cellular roles make selective pharmacologic modulation challenging and potentially toxic[5].

Other names
Chaperone Ric-8ASynembryn-ASynembrynRIC8resistance to inhibitors of cholinesterase 8 homolog A
02

Mechanism of action

RIC8A acts as a guanine nucleotide exchange factor by catalyzing release of GDP from Gα-subunits, allowing GTP binding and activation[1][3][4]. Functions as a molecular chaperone, enabling correct folding, stability, and cellular localization of Gα-subunits[5][7][3][2]. This action is independent of cell-surface G protein-coupled receptors (GPCRs). Phosphorylation by Casein Kinase II stimulates both GEF and chaperone activities[3][4].

03

Biological functions

Signal transduction (by activating heterotrimeric G protein α-subunits)Cell cycle regulation (especially asymmetric cell division)Regulation of G protein localization and membrane associationProtein folding (molecular chaperone for Gα-subunits)Developmental processes (embryogenesis and neurodevelopment)
04

Disease associations

Neurodevelopmental disorders (evidence in cell polarity and asymmetric cell division defects)Embryonic lethality when mutated (model organisms)Potential roles in cancer (due to effects on cell signaling and polarity)Other (broadly impacts diverse G-protein signaling pathways)
05

Safety considerations

Genetic knockout of RIC8A is embryonic lethal in model organisms, suggesting broad, essential cellular roles and high risk for systemic toxicity if targeted[5].Severe disruption of normal G-protein signaling and developmental processes could be expected with RIC8A inhibition[5][7].Off-target effects could be extensive due to RIC8A’s involvement in many cell types and pathways[5][7].No direct pharmacologic inhibitors are in clinical use, so safety concerns are mostly theoretical[5].

Beyond the preview

Go deeper on Resistance to inhibitors of cholinesterase-8A (RIC8A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resistance to inhibitors of cholinesterase-8A (RIC8A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call